Alopecia Areata Market Growth Outlook Through 2024-2033

Overview and Scope
Alopecia areata, also known as spot baldness, refers to an autoimmune disorder where the immune system targets hair follicles, resulting in hair loss and patchy bald spots on the scalp, each about the size of a coin. It is a non-scarring condition that can affect individuals of all ages and characterized by the sudden loss of hair in small, soft, hairless patches.

Sizing and Forecast
The alopecia areata market size has grown strongly in recent years. It will grow from $3.31 billion in 2023 to $3.55 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to limited treatment options, advancements in immunology, increased disease awareness, clinical trials and drug development, psychosocial impact awareness.

The alopecia areata market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to biologic therapies development, precision medicine approaches, advancements in immunotherapy, ai and drug discovery, global initiatives and funding. Major trends in the forecast period include topical immunotherapy advancements, combination therapies, telemedicine in dermatology, patient-centric care, regulatory pathways for novel therapies.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/alopecia-areata-global-market-report

Segmentation & Regional Insights
The alopecia areata market covered in this report is segmented –

1) By Type: Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis Alopecia, Other Types
2) By Treatment: Medical Treatments, Natural Treatment, Other Treatments
3) By Diagnosis: Trichoscopy, Skin Biopsy, Other Diagnoses
4) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

North America was the largest region in the alopecia areata market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia areata market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12596&type=smp

Major Driver Impacting Market Growth
The growing prevalence of hair loss is expected to propel the growth of the alopecia areata market going forward. Hair loss is caused by disrupting the body’s normal hair growth cycle. Alopecia areata treatment employs corticosteroids, potent anti-inflammatory medications that can inhibit the immune system, to treat a condition where the immune system destroys hair follicles and results in hair loss. For instance, in March 2022, according to an article by the Hair Society, a US-based full-service professional organization, hair loss affected about 21 million women and 35 million men globally. The majority of people in the world will lose their hair starting at age 35, with a 40% loss rate for males and increasing to a 70% loss rate for men at age 80. Women with hair loss will account for 80% or more by age 60. Therefore, the growing prevalence of hair loss is driving the growth of the alopecia areata market.

Key Industry Players
Major companies operating in the alopecia areata market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., GlaxoSmithKline plc., Eli Lilly and Co Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Bausch Health Companies Inc., Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Taisho Pharmaceutical Holdings Co. Ltd., Lupin Ltd., Glenmark Pharmaceuticals Ltd., Almirall S.A., Torrent Pharmaceuticals Ltd., Ranbaxy Laboratories Limited, Taro Pharmaceutical Industries Ltd., G&W Laboratories Inc., Vanda Pharmaceuticals Inc., Aclaris Therapeutics Inc., BioSplice Therapeutics Inc., XBiotech Inc., PureTech Health plc, HCell Inc., Histogen Inc.

The alopecia areata market report table of contents includes:

1. Executive Summary
2. Alopecia Areata Market Characteristics
3. Alopecia Areata Market Trends And Strategies
4. Alopecia Areata Market – Macro Economic Scenario
5. Global Alopecia Areata Market Size and Growth
.
.
.
32. Global Alopecia Areata Market Competitive Benchmarking
33. Global Alopecia Areata Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Alopecia Areata Market
35. Alopecia Areata Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model